baber/WOPTO huggingface dataset:
Patent NZ-510884-A (NZ)
Title: System and method for electronically signalling along a fence line having transmitter and receiver and a carrier frequency is phase modulated with a control signal
Inventor: DEUSS EBERHARD JUERGEN
IPC: H05C3/00
Filed: 1999-10-14
Abstract: A system for electronically signalling along a fence line, comprising one or more transmitter device(s) for connection to the fence line from which control signals or information may be sent along the fence line and one or more receiver device(s) for connection to the fence line to receive control signals. Each transmitter device includes transmission means arranged to form the control signal(s) or information as one or more data blocks, generate a carrier frequency, and phase modulate the carrier with the signal and apply the phase modulated carrier to the fence line. Each receiver device includes means arranged to demodulate the transmitted signal to recover the data block(s) and process the data block(s) to recover the control signal(s) or information. The system is adapted to work with both electric and non-electric fence lines.
Patent NZ-515328-A (NZ)
Title: Acoustic device having a member supporting resonant bending wave modes and having a non-modal axis orthogonal to the modal axis
Inventor: BANK GRAHAM
IPC: H04R7/06
Filed: 2000-06-07
Abstract: An acoustic device has a plurality of resonant bending wave modes along the length of a member (1).  The fundamental frequency of resonant bending wave modes in directions perpendicular to the length is much higher, so that the lower frequency resonant bending wave modes are substantially one directional.  A plurality of transducers (5) may be spaced across the width of the member (1) at a preferred position (3) along the length of the panel (1).
Patent NZ-515386-A (NZ)
Title: Ceramic wound treatment device
Inventor: EISELEN ERNST RICHARD
IPC: A61L15/42
Filed: 2000-05-08
Abstract: This invention relates to a ceramic wound treatment device and to a method of treating a wound using such device. The treatment device comprises a plurality of separate inert porous ceramic particles which are contained in a permeable tea-bag type container. The particles have a porosity of between 25 % and 85 %, preferably 75 % and the pores have diamters in the range of between 0.4 to 30 micrometers. The pores are cellular in nature and are interconnected by blow-holes. The particles are manufactured by pulverising an inert microporous ceramic body and removing fine powder from the particles, such that the particles have a diameter range of between 45 and 300 micrometers.
Patent NZ-515683-A (NZ)
Title: An anchor for compressing a wood or sheetlike portion to masonary or solid structure whereupon the anchor has a sleeve which is axially compressible or collapsible
Inventor: POURTIER FABRICE
IPC: F16B13/12
Filed: 2001-11-26
Abstract: An anchor having an expanding sleeve (2) arranged around a threaded shank (9) engaged in a plug (3) for expanding the sleeve (2). The sleeve (2) having an axially compressible portion (16). The anchor is characterised in that the compressible sleeve portion (16) comprises means (24) that can be sheared and which are arranged so that after they have been sheared, they allow the sleeve (2) to be shortened axially.
Patent NZ-518027-A (NZ)
Title: 4-Substituted carbazole or tetrahydrocarbazole derivatives useful as sPLA2 inhibitors
Inventor: ANDERSON BENJAMIN ALAN
IPC: C07D209/82
Filed: 1999-04-16
Abstract: A compound is selected from: 9-benzyl-5,7-dimethoxy-1,2,3,4-tetrahydrocarbazole-4-carboxylic acid hydrazide; 9-benzyl-5,7-dimethoxy-1,2,3,4-tetrahydrocarbazole-4-carboxamide; [9-benzyl-4-carbamoyl-7-methoxy-1,2,3,4-tetrahydrocarbazol-5-yl]oxyacetic acid, sodium salt; [9-benzyl-4-carbamoyl-7-methoxy-1,2,3,4-tetrahydrocarbazol-5-yl]oxyacetic acid, ethyl ester; [9-benzyl-4-carbamoyl-7-methoxycarbazol-5-yl]oxyacetic acid; methyl [9-benzyl-4-carbamoyl-7-methoxycarbazol-5-yl]oxyacetic acid; 9-benzyl-7-methoxy-5-cyanomethyloxy-1,2,3,4-tetrahydrocarbazole-4-carboxamide; 9-benzyl-7-methoxy-5-((1H-tetrazol-5-yl-methyl)oxy)-1,2,3,4-tetrahydrocarbazole-4-carboxamide; {9-[(phenyl)methyl]-5-carbamoyl-2-methyl-carbazol-4-yl}oxyacetic acid; [(phenyl)methyl]-2-methyl-5-carbamoylcarbazol-4-yloxyacetic acid, methyl ester; [5-carbamoyl-2-pentyl-9-(phenylmethyl)carbazol-4-yl]oxyacetic acid; [5-carbamoyl-2-pentyl-9-(phenylmethyl)carbazol-4-yl]oxyacetic acid, methyl ester; [5-carbamoyl-2-(1-methylethyl)-9-(phenylmethyl)carbazo1-4-yl]oxyacetic acid; [5-carbamoyl-2-(1-methylethyl)-9-(phenylmethyl)carbazo1-4-yl]oxyacetic acid, methyl ester; [(phenyl)methyl]-5-carbamoylcarbazol-4-yloxyacetic acid, methyl ester; [9-benzyl-4-carbamoyl-1,2,3,4-tetrahydrocarbazol-5-yl]oxyacetic acid; [9-benzyl-4-carbamoyl-1,2,3,4-tetrahydrocarbazole-5-yl]oxyacetic acid, methyl ester; [9-benzyl-4-carbamoyl-8-methyl-1,2,3,4-tetrahydrocarbazol-5-yl]oxyacetic acid; [9-benzyl-4-carbamoyl-8-methyl-1,2,3,4-tetrahydrocarbazol-5-yl]oxyacetic acid, methyl ester; [9-benzyl-5-carbamoyl-1-methylcarbazol-4-yl]oxyacetic acid; [9-benzyl-5-carbamoyl-1-methylcarbazol-4-yl]oxyacetic acid methyl ester; 9-benzyl-7-methoxy-5-cyanomethyloxy-carbazole-4-carboxamide; 9-benzyl-7-methoxy-5-((1H-tetrazol-5-yl-methyl)oxy)-carbazole-4-carboxamide; {9-[(phenyl)methyl]-5-carbamoylcarbazol-4-yl}oxyacetic acid; 9-benzyl-4-carbamoyl-5,7-dimethoxycarbazole; [9-benzyl-4-carbamoyl-7-methoxycarbazol-5-yl]oxyacetic acid, methyl ester; 9-benzyl-5-methoxy-8-methyl-1,2,3,4-tetrahydrocarbazole-4-carboxamide; and 9-benzyl-5-carbamoyl-4-methoy-1-methylcarbazole or a pharmaceutically acceptable racemate, solvate, tautomers, optical isomer or salt thereof. The above-described compounds are useful in alleviating the pathological effects of sPAL2 related diseases and for inhibiting. sPAL2 mediated release of fatty acid thereby inhibiting or preventing arachidonic acid cascade.
Patent NZ-518285-A (NZ)
Title: Multilayer film for packaging article
Inventor: VADHAR PARIMAL M
IPC: B32B27/32
Filed: 2000-10-11
Abstract: A two component laminated multilayer film suitable  for use  in packaging articles such as pet food comprises: I.  a first  component comprising: (A) an outer first  film  layer comprising ethylene/alpha-olefin copolymer; (B) an  optional second  film  layer comprising at least one member  selected from  the  group  consisting  of ethylene/unsaturated  ester copolymer,      anhydride-modified     ethylene/alpha-olefin copolymer,   anhydride-modified  ethylene/ester   copolymer, acid-modified  ethylene/alpha-olefin  copolymer,  and  acid- modified  ethylene/acid copolymer;  (C)  an  optional  third film  layer comprising ethylene/alpha-olefin copolymer;  and II.  a  non  heat-shrinkable second component  laminated  to said first component, said second component comprising:  (D) an  outer  fourth film layer which comprises  at  least  one member selected from the group consisting of ethylene/alpha- olefin  copolymer and ethylene/unsaturated ester  copolymer; (E)  a  fifth film layer which serves as an O2-barrier layer between  the  third  film layer and the fourth  film  layer, selected    from   PVDC,   EVOH,   polyalkylene   carbonate, polyacrylonitrile,  polyamide, and polyester;  (F)  a  sixth film  layer between the fourth film layer and the fifth film layer, serving as a first tie layer; and (G) a seventh  film layer  which is between the third film layer and  the  fifth film  layer, the seventh film layer serving as a second  tie layer;  wherein the multilayer film is sealable to at  least one  member selected from the group consisting of itself and another   film;  and  wherein  a  surface  of  said   second component  is  heat sealable to itself as well  as  to  said layer (A) of said first component.
Patent NZ-520083-A (NZ)
Title: The modification of a patient's blood with ultra-violet light for the treatment of congestive heart failure
Inventor: SMITH ELDON R
IPC: A61K41/00
Filed: 2001-01-18
Abstract: The use of an aliquot of modified blood of a patient's blood to treat congestive heart failure (CHF) in a human patient.  The blood is treated ex vivo with stressors comprising ultraviolet light and an oxidative environment   A medicament is also used for the treatment of congestive heart failure which contains an aliquot of the patient's blood which has been treated ex vivo with one or more stressors selected from an oxidative environment, thermal stress and electromagnetic emission and a pharmaceutical agent selected from the group consisting of nitrates, b-blockers, ACE inhibitors, AT receptor blocking agents, aldosterone antagonists, calcium channel blocking agents, TNF blocking agents, suppressors of production of TNF-a, sodium and fluid restriction, diuretics and digitalis.
Patent NZ-520259-A (NZ)
Title: Transgenic goat producing milk containing human granulocyte-colony stimulating factor
Inventor: CHOI IN-YOUNG
IPC: C12N15/85
Filed: 2001-01-26
Abstract: A transgenic goat or goat zygote is developed from a goat zygote comprising a nucleic acid construct containing a nucleotide sequence of a goat beta-casein promoter and a nucleotide sequence encoding hG-CSF, which produces milk containing a high concentration of biologically active hG-CSF. Such milk is useful for the production of pharmaceutical compositions comprising hG-CSF.
Patent NZ-522088-A (NZ)
Title: Long-term treatment with triiodothyronine for treating congestive heart failure (CHF)
Inventor: KLEIN IRWIN
IPC: A61P9/04
Filed: 2001-03-16
Abstract: The use of hormone triiodothryonine (T3) is described in a method for chronic treatment of congestive heart failure (CHF) in a patient having CHF. The method entails oral administration of T3 daily over the long-term, and may be in the form of a sustained release formulation.
Patent NZ-523644-A (NZ)
Title: Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
Inventor: LENAERTS VINCENT
IPC: A61K31/137
Filed: 2001-06-26
Abstract: A form of cross-linked high amylase starch and a process for its manufacture is disclosed. The described cross-linked high amylase starch is useful as an excipient in a controlled-release pharmaceutical formulation when compressed with a pharmaceutical agent(s) in a tablet. Such cross-linked high amylase starch is prepared by a) cross-linking and chemical modification of high amylase starch, b) gelatinization, and c) drying to obtain a powder of said controlled release excipient. The cross-linked high amylase starch may be prepared in the following steps: 1) granular cross-linking and additionally chemical modification, such as hydroxypropylation, of high-amylose starch; 2) thermal gelatinization of the starch from step 1); and 3) drying the starch from step 2) to yield a powder capable of being used as a controlled release excipient.
Patent NZ-524681-A (NZ)
Title: A method for treating allergies using substituted pyrazoles
Inventor: BUTLER CHRISTOPHER R
IPC: A61K31/13
Filed: 2001-09-05
Abstract: The use of a compound of formula (I), or a pharmaceutically acceptable salt, amide, or ester; or a stereoisomeric form, is described to be used in the preparation of a medicament for the treatment of an allergic condition. Ar2 is disclosed to be a monocyclic or bicyclic ring system, unsaturated, saturated or aromatic, optionally fused, optionally including from 1 to 5 heteroatom ring moieties independently selected from 0, S N, SO2, and C=O; said Ar2 ring system being optionally substituted; R5 and R6 are independently selected from hydrogen and C1-5 alkyl; R7 and R8 are independently hydrogen, C1-5 alkyl, C2-5 alkenyl, C1-5 alkoxy, C1-5 alkylthio, halogen, or a 4-7 membered carbocyclyl or heterocyclyl; alternatively, R7 and R8 can be taken together to form an optionally substituted 5- to 7- membered carbocyclic or heterocyclic ring, which ring may be unsaturated or aromatic, and may be optionally substituted; n is O,1,or 2; G is C3-6 alkenediyl or C3-6 alkanediyl, optionally substituted; Ar represents a monocyclic or bicyclic aryl or heteroaryl ring, optionally substituted; W represents 0, S, NR27, C=O, (C=O)NH, NH(C=0), CHR28, or a covalent bond; RZ is H or OH and the dashed line is absent; or Rz is absent where the dashed line is an sp2 bond.
Patent NZ-527343-A (NZ)
Title: Modular system for the control of compression systems for the compression of a fluid medium
Inventor: SAARINEN VESA
IPC: F04B49/06
Filed: 2002-02-04
Abstract: Modular system for the control of at least one compression system for the compression a fluid medium, comprises: compressors (C1-C7) and their controllers (A1-A7) for the compression of the fluid medium, secondary treatment devices for the treatment of the medium delivered from the compressors, and piping systems (17-19, 23) for conducting the fluid medium to a place of consumption (16, 22), the control system comprises a control unit (3) containing a data processing system (34) for controlling the compression system, a user interface (35) including a display associated with it and transmission means for the transmission of control data between the control unit, the controllers and pressure sensors, wherein the transmission means comprises at least one data communication bus and a data communication port unit (33) serving to connect the bus to the control unit (34), and wherein the controllers and the pressure sensors are connected in common to the control unit by at least one data communication bus.
Patent NZ-527583-A (NZ)
Title: Use of flumazenil in developing a drug for the treatment of alcohol dependence
Inventor: IBANEZ JUAN JOSE LEGARDA
IPC: A61K31/557
Filed: 2002-01-10
Abstract: A method for the treatment of alcohol dependency comprises administrating at therapeutically effective amount of flumazenil at quantities of between 0.2 and 0.3 mg sequentially at time intervals between 1 and 15 minutes. Preferably the therapeutically effective amount of flumazenil is 2mg/day.
Patent NZ-529113-A (NZ)
Title: Container for shaving cartridge or other stored item
Inventor: PETRICCA JOHN D
IPC: B65D1/40
Filed: 2003-10-23
Abstract: Sealed package (10) that includes a formed plastic container (12), a shaving cartridge (16) (or other stored unit) in a storage region (18) in the container, and a removable film (14) that covers and is sealed to a sealing surface (20) around an entrance (22) to the storage region. A plastic tab (24) is attached to a portion of the film extending beyond the sealing surface of the container to initiate peeling of the film from the sealing surface. The plastic tab is spaced from the formed plastic container by a gap. (62) Divided Out of 516628
Patent NZ-529240-A (NZ)
Title: Two-compartment container
Inventor: MOLLSTAM BO
IPC: B65D81/32
Filed: 2002-04-26
Abstract: A two-compartment container in which the first compartment has an upper layer and a lower layer and contains a first component that is to be added to the second compartment. Above the first compartment is a dome that is bowed upward and is flexible. Attached to the dome is a cutting means. Depressing the dome by pushing downward on it lowers the cutting means so that wither the lower layer only or both the upper and lower layer of the first compartment are cut by the cutting means, releasing the first component into the second compartment. The cutting means may be a simple puncturer, or in the case where the second compartment comprises a beverage container or the like, the cutting means may be part of a tubular wall surrounding the opening through which someone can drink the beverage.
Patent NZ-534516-A (NZ)
Title: Shirred elastic sheet material
Inventor: SLEIGHT GREG W
IPC: B65D33/00
Filed: 2003-09-19
Abstract: A bag (100) including a retaining element (120). The bag has first and second side walls (102,104). The retaining element is in the form of an elastic strip attached to one of the side walls and extends substantially continuously between the first and second side walls. The retaining element has a multiple layer construction, and may comprise a heat-unstable activatable material such that it can be applied to the bag in a deadened condition wherein the strip is set and subsequently heated to transition to an activated condition wherein the retaining element is elasticized to provide an elasticized article which can have a shirred appearance.
Patent NZ-538921-A (NZ)
Title: A cistern outlet valve mounting bracket assembly and a method of installing an outlet valve in a cistern
Inventor: ENGLAND SAM ROBERTSON
IPC: E03D1/34
Filed: 2003-08-28
Abstract: A cistern outlet valve mounting bracket assembly (10). The assembly includes first and second bracket members (12, 14) adapted for positioning about an outlet valve (20) in engagement with each other and the valve. The members also have means (28, 32) to allow fixing of the engaged members to a cistern (38). A method of installing an outlet valve in a cistern is also disclosed.
Patent NZ-547168-A (NZ)
Title: Glycopegylated erythropoietin
Inventor: DEFREES SHAWN
IPC: A61K38/18
Filed: 2004-11-24
Abstract: Disclosed are conjugates between erythropoietin and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. Also disclosed are methods for preparing the conjugates and methods for treating various disease conditions with the conjugates.
Patent NZ-552387-A (NZ)
Title: Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Inventor: JONES ROBERT M
IPC: C07D413/12
Filed: 2005-06-02
Abstract: Disclosed is a compound of formula (I) or a pharmaceutical acceptable salt, solvate, hydrate, or N-oxide thereof, wherein the substituents are as defined in the specification. Also disclosed, is the use of the compound in the manufacture of a medicament for the treatment of metabolic diseases, including: type I diabetes; type II diabetes; inadequate glucose tolerance; insulin resistance; hyperglycemia; hyperlipidemia; hypertriglyceridemia; hypercholesterolemia; dyslipidemia; and syndrome X.
Patent NZ-560241-A (NZ)
Title: Knock down stand for supporting an object on uneven or sloping ground
Inventor: HORTON PETER DONALD
Filed: 2007-07-31
Abstract: A stand (60) suitable for supporting an object on uneven or sloping ground is disclosed. The stand (60) is an assembly of at least three sleeve members (66) which are each adapted to slidably receive a respective longitudinal leg (82) so that the distal ends of the legs (76) engage the ground to support the sleeve assembly above the ground at an orientation selectable by sliding at least one longitudinal leg (82) with respect to a respective sleeve member (66). The sleeve members (66) are arranged and angled so as to retain their respective legs (82) in a selected relative position by virtue of frictional engagement between the longitudinal leg (82) and the sleeve member (66) arising from the weight of the stand (60). A vertical sleeve member is arranged within the assembly to receive a vertical member to complete the stand (60).
Patent NZ-563239-A (NZ)
Title: Fluorene derivatives, composition containing said derivatives and the use thereof as HSP90 inhibitors
Inventor: MAILLIET PATRICK
IPC: C07D471/04
Filed: 2006-05-19
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds have Hsp90 chaperone protein-inhibiting activity and are useful in the treatment of cancer.
Patent NZ-563708-A (NZ)
Title: Scalable fermentation process
Inventor: EMMERLING MARCEL
IPC: C12N7/02
Filed: 2006-05-24
Abstract: A process for expression of a recombinant capsid protein of a bacteriophage or a mutant or fragment thereof being capable of forming a VLP by self-assembly, wherein said bacteriophage is a RNA bacteriophage, and wherein said process comprising the steps of: a.) introducing an expression plasmid into a bacterial host, wherein said expression plasmid comprises an expression construct, wherein said expression construct comprises (i) a first nucleotide sequence encoding said recombinant capsid protein, or mutant or fragment thereof, and (ii) a promoter being inducible by lactose; b.) cultivating said bacterial host in a medium comprising a major carbon source; wherein said major carbon source is glucose or glycerol; and wherein said cultivating is performed in batch culture and under conditions under which said promoter is repressed by lac!, wherein said lac! is overexpressed by said bacterial host; c.) feeding said batch culture with said major carbon source; and d.) inducing said promoter with an inducer, wherein said feeding of said batch culture with said major carbon source is continued.
Patent NZ-574732-A (NZ)
Title: Through surface sealing device and method
Inventor: FRANCE GEOFFREY JAMES
IPC: E04D13/00
Filed: 2009-02-05
Abstract: A method of sealing a penetration through a surface (not shown), typically a roof, is disclosed and includes the following steps: (i) passing through the penetration a service tube 50 having cut-out at a first end; (ii) sealing the service tube to the surface using a boot flashing 30, with an optional over-flashing 40; (iii) providing at the fist end of the service tube a cap 60; such that services (not shown) can pass from a first side of the surface to a desired end point on a second side of the surface via the service tube, bend through the cut-out section and, protected by the cap, return some distance towards the surface before reaching the desired end point. A kit of parts including the boot flashing, service tube and cap is also disclosed.
Patent NZ-586314-A (NZ)
Title: Process for the production of algal biomass with a high lipid content
Inventor: RISPOLI GIACOMO
IPC: C12N1/12
Filed: 2008-12-03
Abstract: Disclosed is a process for the production of algal biomass with a high lipid content comprising the following steps: (a) the production of inocula in photoreactors; (b) the cultivation of the algal biomass in open ponds, inoculated with the inocula obtained in step (a); (c) a thickening step of the algal biomass obtained in step (b) ; (d) an induction step of the lipid production of the thickened algal biomass obtained in step (c), which is carried out in photoreactors or open ponds; (e) a separation step of the algal biomass obtained in step (d) obtaining a biomass with a high lipid content and an aqueous phase.
Patent NZ-588493-A (NZ)
Title: Geothermal power plant
Inventor: TORVUND STIG
IPC: F03G7/04
Filed: 2009-03-17
Abstract: 599493 A geothermal power plant system for extracting geothermal energy from at least one drillbore for producing electric power, comprises a plurality of geothermal container units each formed by one or more containers, where each of the geothermal container units is connected to at least one respective drillbore in a flash cycle, is modularized, and is containerised so as to fit into the one or more containers, and an electrical cable provided from each the geothermal container units for electrically connecting to others of the geothermal container units and to an electrical grid so as to form a geothermal power plant system arranged in a network.
Patent NZ-591363-A (NZ)
Title: Coal processing operation including a dense media separation stage and coal gasification
Inventor: VAN DYK JOHANNES CHRISTOFFEL
IPC: C10J3/54
Filed: 2009-05-14
Abstract: Disclosed is a coal processing method (10). In a dense media separation stage (12), a coal feedstock (18) which includes minerals is subjected to dense media separation producing a first coal stream (20) and a second coal stream (22). Coal in the first coal stream is lower in ash and has a lower ash fusion temperature than coal in the second coal stream. Coal from the first coal stream is processed in a high temperature coal processing operation (14), and coal from the second coal stream is processed in a medium temperature coal processing operation (16).